rethinkTHC Search
Menu
Study breakdown

Pre-Transplant Cannabis Use Linked to Higher Immediate Opioid Needs But No Worse Liver Transplant Outcomes

Retrospective CohortModerate evidence
The takeaway

Cannabis users needed more opioids in the first 48 hours after liver transplant, but this did not translate to worse outcomes for hospital stay, readmission, or mortality.

Transplant candidates who use cannabis, transplant providers, and policy analysts.

No difference in 90-day readmission or mortality

What the researchers found

Among 4,236 patients, cannabis users required significantly more opioids in the 48 hours after transplant (p=0.04). No significant differences in opioid use beyond 48 hours, discharge opioid prescriptions, hospital or ICU length of stay, 90-day readmission, or 90-day mortality.

Why it matters

Some transplant centers still consider cannabis use a barrier to eligibility. This data supports growing evidence that pre-transplant cannabis use does not worsen outcomes.

The numbers in context

4,236 patients. Higher opioids at 48 hours (p=0.04). No difference at 72 hours (p=0.07) or 7 days (p=0.33). No difference in LOS (p=0.69), ICU LOS (p=0.94), readmission (p=0.66), or mortality (p=0.96).

How the study worked

Retrospective cohort of 4,236 patients evaluated for liver transplant (January 2013-July 2023). Cannabis use defined as positive urine toxicology within 90 days. Multivariable regression compared outcomes.

What this study cannot tell us

Single-center retrospective. Cannabis defined by single urine test. No data on type or frequency of use.

How to read the evidence

Moderate: large retrospective cohort with multivariable adjustment, but single-center and crude exposure measure.

When this study was published

Published in 2025, with data from 2013-2023.

The bigger picture

Cannabis use has historically been used to deny organ transplant listing. This study challenges those policies by showing no association with worse outcomes.

Questions still open

  • Should transplant centers update policies?
  • Why do cannabis users need more opioids immediately after surgery?
  • Does the type of cannabis use matter for outcomes?

Common questions

Does cannabis use affect liver transplant outcomes?
This study found cannabis users needed slightly more pain medication in the first 48 hours, but there was no difference in hospital stay, readmission, or survival.
Can cannabis users receive organ transplants?
Policies vary, but this study adds to growing evidence that pre-transplant cannabis use does not worsen outcomes.

Read the original research

Cannabis and liver transplant in the era of legalization: Effects of pretransplant cannabis use on postoperative opioid use and transplant outcomes.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 31(11), 1398-1410

Citation

Runge, Ava; Loeb, Becca; Shui, Amy M; Fenton, Cynthia; Lai, Jennifer; Rubin, Jessica. (2025). Cannabis and liver transplant in the era of legalization: Effects of pretransplant cannabis use on postoperative opioid use and transplant outcomes.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 31(11), 1398-1410. https://doi.org/10.1097/LVT.0000000000000585

Explore the wider topic